Research Article
Predictors of Mortality among Adult Antiretroviral Therapy Users in Southeastern Ethiopia: Retrospective Cohort Study
Table 2
Clinical characteristics of ART clients, Goba Hospital, Southeast Ethiopia, 2013.
| Baseline* characteristics | Number | Percent |
| Baseline functional status | | | Working | 1646 | 80.8 | Ambulatory | 276 | 13.6 | Bedridden | 114 | 5.6 | WHO stage at ART initiation | | | WHO stage I | 422 | 20.7 | WHO stage II | 304 | 14.9 | WHO stage III | 1196 | 58.7 | WHO stage IV | 114 | 5.6 | Baseline CD4 count | | | ≤200 | 1705 | 85.5 | 201–300 | 252 | 12.6 | >300 | 37 | 1.9 | Median CD4 (mm3) (IQR) | 121.0 (169.0–64.0) mm3 | | Baseline HgB level | | | Anemic | 383 | 43.3 | Nonanemic | 501 | 56.7 | Median HgB (mg/dL) (IQR) | 13.6 mg/dL (11 mg/dL–14.6 mg/dL) | Patient screened for TB | | | Yes | 1940 | 95.3 | No | 96 | 4.7 | TB coinfection at initiation of ART | | | Positive | 285 | 14.7 | Negative | 1655 | 85.3 | Baseline BMI | | | <18.5 | 11 | 1.3 | 18.5–24.9 | 756 | 88.6 | ≥25.0 | 86 | 10.1 | Median weight (Kg) (IQR) | 50.0 Kg (57 Kg–45 Kg) |
|
|
Baseline indicates measurements at initiation of ART.
|